Related Experiment Video
Updated: Sep 14, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Influence of perinatal antibiotic on neonatal gut microbiota: a prospective cohort study
Faiza Iqbal1, Padmaja A Shenoy2, Leslie Edward S Lewis3
1Department of Pediatrics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Udupi District, Manipal, Karnataka, 576104, India.
Insights
Perinatal antibiotic exposure significantly alters the preterm infant gut microbiome, increasing pathogenic bacteria like Klebsiella pneumoniae and decreasing beneficial Bifidobacterium spp.
Area of Science:
- Microbiology
- Neonatal Medicine
- Pediatrics
Background:
- The gut microbiome plays a critical role in early immune and metabolic development.
- Perinatal antibiotic administration significantly impacts the neonatal gut microbiome.
- Understanding these effects is crucial for preterm infant health.
Purpose of the Study:
- To investigate the impact of maternal and neonatal antibiotic exposure on the gut microbiome composition in preterm infants.
- To compare microbiome profiles across different antibiotic exposure groups.
Main Methods:
- Prospective controlled cohort study in a neonatal intensive care unit.
- Inclusion of preterm infants (gestational age < 37 weeks).
- Categorization into four groups: no exposure, infant exposure only, maternal exposure only, and both infant and maternal exposure. Stool sample analysis via convection culture.
Main Results:
- Antibiotic exposure (infant, maternal, or both) increased the abundance of potentially pathogenic bacteria (Klebsiella pneumoniae, Escherichia coli).
- Beneficial bacteria (Bifidobacterium spp.) were more abundant in infants with no antibiotic exposure.
- Klebsiella pneumoniae prevalence significantly increased in infants with exposure by day 4.
Conclusions:
- Perinatal antibiotic exposure is linked to significant alterations in the neonatal gut microbiota.
- These changes may lead to an increased abundance of pathogenic bacteria.
- Findings highlight the potential risks of antibiotic use in the perinatal period for preterm infants.
Introduction:
Given the significant role of the gut microbiota in early immune and metabolic development, the impact of perinatal antibiotic administration on the neonatal gut microbiome remains a crucial area of investigation. This study examines how maternal and neonatal antibiotic exposure affects the composition of the gut microbiome in preterm infants.
Methodology:
A prospective controlled cohort study was conducted in the neonatal intensive care unit of a tertiary care hospital from January 2021 to September 2023. The study enrolled neonates with a gestational age of less than 37 weeks. Preterm infants were categorized into four groups based on exposure to maternal or neonatal antibiotics: the NE group (no exposure), IE group (infant exposure only), ME group (maternal exposure only), and IME group (both infant and maternal exposure). In the NE group, "No exposure" refers to participants whose mothers did not receive intrapartum antibiotics or whose neonates were not administered postnatal antibiotics prior to sample collection. Data on antibiotic use and microbiota composition from stool samples were collected and analyzed via the convection culture method.
Results:
This study included 182 preterm infants, yielding 364 stool samples. By day 4, the prevalence of Klebsiella pneumoniae increased significantly, reaching 70% in the IE group compared with 42.6% in the NE group (p < 0.001). Bifidobacterium spp. was more prevalent in the NE group than in the other groups on day 4 (57.4%, p = 0.019). The antibiotic-exposed groups (IE, ME, and IME groups) presented greater abundances of potentially pathogenic bacteria, such as Klebsiella pneumoniae and Escherichia coli, whereas beneficial bacteria, such as Bifidobacterium spp., were more abundant in the NE group.
Conclusion:
These findings suggest that perinatal antibiotic exposure is associated with significant changes in the neonatal gut microbiota, potentially increasing the pathogenic microbiota.
Trial Registration:
The study was registered with the Clinical Trials Registry-India (CTRI) under the number CTRI/2020/11/029375 | http://ctri.nic.in/ on November 19, 2020.
More Related Videos
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Development of Antibiotic Resistance
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

